INVO Bioscience
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $1,836 | $1,576 | $1,381 | $974 |
Gross Profit | 744 | 499 | 495 | 393 |
EBITDA | -1,645 | -1,186 | -873 | |
EBIT | -1,875 | -1,413 | -894 | |
Net Income | -2,245 | -1,596 | -1,994 | -1,248 |
Net Change In Cash | 1,836 | 1,576 | 1,381 | 974 |
Free Cash Flow | -1,510 | -310 | -789 | -1,355 |
Cash | 942 | 475 | 232 | 1,055 |
Basic Shares | 3,609 | 3,801 | 2,492 | 1,776 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $3,020 | $822 | $4,160 | $1,037 |
Gross Profit | 1,086 | 490 | 4,015 | 948 |
EBITDA | -6,880 | -10,826 | -5,216 | -5,476 |
EBIT | -7,080 | -10,626 | -5,382 | -5,510 |
Net Income | -8,034 | -10,892 | -6,654 | -8,347 |
Net Change In Cash | 3,020 | 822 | 4,160 | 1,037 |
Free Cash Flow | -5,199 | -6,616 | -6,484 | -4,864 |
Cash | 232 | 90 | 5,684 | 10,097 |
Basic Shares | 1,565 | 606 | 531 | 274 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.62 |
2024-03-31 | -$0.80 |
2023-09-30 | -$0.70 |
2023-06-30 | -$3.06 |
